Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...
The U.S. Food and Drug Administration (FDA) is taking active steps to improve disclosure of gluten ingredients in foods.
The agency issued a request for more information that will shape new regulation on ingredient transparency.
FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
Glaukos Corporation (GKOS) added ~7% on Wednesday after the U.S. Food and Drug Administration approved a labeling change for ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.
On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...
The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation and behavior from their labels following an investigation, the agency stated ...
January 13, 2026 - PRESSADVANTAGE - In the highly regulated field of medical device labeling translation, ensuring that ...
The U.S. Food and Drug Administration (FDA) started 2025 with new guidance on non-listed food allergens after detailing requirements CPG companies must follow to label the top nine allergens in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results